The FDA approved the distribution of new pancreatic cancer drug Onivyde. However, because of its several consideraby fatal side effects, boxed warnings are to be included to guide clinicians in prescribing the drug.
FDA Approves Merrimack's Pancreatic Cancer Drug Onivyde But Treatment Comes With Boxed Warning
Tech Times - 23 Oct 2015 13:56
The FDA approved the distribution of new pancreatic cancer drug Onivyde. However, because of its several consideraby fatal side effects, boxed warnings are to be included to guide clinicians in prescribing the drug.
Share this Article
Recommended